322 related articles for article (PubMed ID: 12574369)
1. NF-kappa B1 is required for optimal CD4+ Th1 cell development and resistance to Leishmania major.
Artis D; Speirs K; Joyce K; Goldschmidt M; Caamaño J; Hunter CA; Scott P
J Immunol; 2003 Feb; 170(4):1995-2003. PubMed ID: 12574369
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell-intrinsic expression of NF-kappa B1 is required to promote optimal Th2 cell differentiation.
Artis D; Kane CM; Fiore J; Zaph C; Shapira S; Joyce K; Macdonald A; Hunter C; Scott P; Pearce EJ
J Immunol; 2005 Jun; 174(11):7154-9. PubMed ID: 15905559
[TBL] [Abstract][Full Text] [Related]
3. NF-kappa B2 is required for optimal CD40-induced IL-12 production but dispensable for Th1 cell Differentiation.
Speirs K; Caamano J; Goldschmidt MH; Hunter CA; Scott P
J Immunol; 2002 May; 168(9):4406-13. PubMed ID: 11970983
[TBL] [Abstract][Full Text] [Related]
4. Differential requirement for NF-kappa B family members in control of helminth infection and intestinal inflammation.
Artis D; Shapira S; Mason N; Speirs KM; Goldschmidt M; Caamaño J; Liou HC; Hunter CA; Scott P
J Immunol; 2002 Oct; 169(8):4481-7. PubMed ID: 12370384
[TBL] [Abstract][Full Text] [Related]
5. Identification of a role for NF-kappa B2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii.
Caamaño J; Tato C; Cai G; Villegas EN; Speirs K; Craig L; Alexander J; Hunter CA
J Immunol; 2000 Nov; 165(10):5720-8. PubMed ID: 11067930
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection.
Artis D; Johnson LM; Joyce K; Saris C; Villarino A; Hunter CA; Scott P
J Immunol; 2004 Apr; 172(8):4672-5. PubMed ID: 15067040
[TBL] [Abstract][Full Text] [Related]
7. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
[TBL] [Abstract][Full Text] [Related]
8. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response.
Muraille E; De Trez C; Brait M; De Baetselier P; Leo O; Carlier Y
J Immunol; 2003 Apr; 170(8):4237-41. PubMed ID: 12682257
[TBL] [Abstract][Full Text] [Related]
9. Semaphorin 3E Promotes Susceptibility to
Ikeogu NM; Edechi CA; Akaluka GN; Feiz-Barazandeh A; Zayats RR; Salako ES; Onwah SS; Onyilagha C; Jia P; Mou Z; Shan L; Murooka TT; Gounni AS; Uzonna JE
J Immunol; 2021 Feb; 206(3):588-598. PubMed ID: 33443083
[TBL] [Abstract][Full Text] [Related]
10. LIGHT Is critical for IL-12 production by dendritic cells, optimal CD4+ Th1 cell response, and resistance to Leishmania major.
Xu G; Liu D; Okwor I; Wang Y; Korner H; Kung SK; Fu YX; Uzonna JE
J Immunol; 2007 Nov; 179(10):6901-9. PubMed ID: 17982081
[TBL] [Abstract][Full Text] [Related]
11. T cell-intrinsic requirement for NF-kappa B induction in postdifferentiation IFN-gamma production and clonal expansion in a Th1 response.
Corn RA; Aronica MA; Zhang F; Tong Y; Stanley SA; Kim SR; Stephenson L; Enerson B; McCarthy S; Mora A; Boothby M
J Immunol; 2003 Aug; 171(4):1816-24. PubMed ID: 12902482
[TBL] [Abstract][Full Text] [Related]
12. Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice.
Anderson CF; Mendez S; Sacks DL
J Immunol; 2005 Mar; 174(5):2934-41. PubMed ID: 15728505
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of type I diabetes by NF-kappa B.
Lamhamedi-Cherradi SE; Zheng S; Hilliard BA; Xu L; Sun J; Alsheadat S; Liou HC; Chen YH
J Immunol; 2003 Nov; 171(9):4886-92. PubMed ID: 14568969
[TBL] [Abstract][Full Text] [Related]
14. Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8+ T cells.
Gurunathan S; Stobie L; Prussin C; Sacks DL; Glaichenhaus N; Iwasaki A; Fowell DJ; Locksley RM; Chang JT; Wu CY; Seder RA
J Immunol; 2000 Jul; 165(2):915-24. PubMed ID: 10878366
[TBL] [Abstract][Full Text] [Related]
15. STAT1 expression in dendritic cells, but not T cells, is required for immunity to Leishmania major.
Johnson LM; Scott P
J Immunol; 2007 Jun; 178(11):7259-66. PubMed ID: 17513775
[TBL] [Abstract][Full Text] [Related]
16. IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection.
Anderson CF; Stumhofer JS; Hunter CA; Sacks D
J Immunol; 2009 Oct; 183(7):4619-27. PubMed ID: 19748991
[TBL] [Abstract][Full Text] [Related]
17. Genetically resistant mice lacking IL-18 gene develop Th1 response and control cutaneous Leishmania major infection.
Monteforte GM; Takeda K; Rodriguez-Sosa M; Akira S; David JR; Satoskar AR
J Immunol; 2000 Jun; 164(11):5890-3. PubMed ID: 10820270
[TBL] [Abstract][Full Text] [Related]
18. IL-12 is required to maintain a Th1 response during Leishmania major infection.
Park AY; Hondowicz BD; Scott P
J Immunol; 2000 Jul; 165(2):896-902. PubMed ID: 10878364
[TBL] [Abstract][Full Text] [Related]
19. IL-7 receptor expression provides the potential for long-term survival of both CD62Lhigh central memory T cells and Th1 effector cells during Leishmania major infection.
Colpitts SL; Dalton NM; Scott P
J Immunol; 2009 May; 182(9):5702-11. PubMed ID: 19380817
[TBL] [Abstract][Full Text] [Related]
20. Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression.
Giese NA; Gabriele L; Doherty TM; Klinman DM; Tadesse-Heath L; Contursi C; Epstein SL; Morse HC
J Exp Med; 1997 Nov; 186(9):1535-46. PubMed ID: 9348311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
